Comment to 'Glucocorticoid resistance syndrome caused by a novel NR3C1 point mutation' by Al Argan et al
Endocr J
.
2019 Jul 28;66(7):657.
doi: 10.1507/endocrj.EJ19-0122.
Epub 2019 Jun 13.
Authors
Salvatore Cannavò
1
2
,
Salvatore Benvenga
3
4
,
Erika Messina
1
,
Mariacarla Moleti
1
3
,
Francesco Ferraù
1
2
Affiliations
1
Endocrine Unit, University Hospital of Messina, Italy.
2
Department of Human Pathology, University of Messina, Italy.
3
Department of Clinical and Experimental Medicine, University of Messina, Italy.
4
Interdept. Program of Molecular & Clinical Endocrinology, University Hospital of Messina, Italy.
PMID:
31189748
DOI:
10.1507/endocrj.EJ19-0122
No abstract available
Publication types
Comment
MeSH terms
Glucocorticoids
Humans
Metabolism, Inborn Errors*
Point Mutation*
Receptors, Glucocorticoid
Substances
Glucocorticoids
NR3C1 protein, human
Receptors, Glucocorticoid